Tsumura & Co.
[Tsumura] Announces Executive Change | June 2026
Tsumura Co., Ltd. announced a change in the position of the President and Representative Director, Kei Sugii, scheduled for June 26, 2026, aiming to strengthen management control and accelerate decision-making.
Key Figures
- Date of Executive Change: June 26, 2026
- New Position: President and COO (兼) President of Medical Pharmaceuticals Business
- Previous Position: President of Medical Pharmaceuticals Business
AI要約
Overview of the Executive Personnel Change
Tsumura Co., Ltd. resolved at an extraordinary Board of Directors meeting to be held on June 26, 2026, to change the position of President and Representative Director to Kei Sugii. Mr. Sugii will assume the roles of Chief Operating Officer (COO) and President of the Medical Pharmaceuticals Business, shifting from the role of President of the Medical Pharmaceuticals Business. This move aims to further enhance the management framework and enable swift decision-making. Mr. Sugii joined Mitsubishi Oil Chemical Engineering in 1994 and has held numerous positions at Accenture and within our company. The new appointment will take effect as of June 26, 2026.
Future Outlook and Corporate Strategy
This executive personnel change is intended to expedite management decision-making and strengthen business competitiveness. Leveraging Mr. Sugii’s extensive experience is expected to accelerate initiatives in the medical pharmaceuticals business and the development of new businesses. Details of the future management policy and medium-term plans are expected to be disclosed continuously, and this will attract investor attention as part of the company's growth strategy.
Tsumura Co., Ltd.
Company overview · Stock price · Financial data · All IR
